The purpose of this study is to investigate the incidence of liver injury by statins in coronary heart disease (CHD) patients with history of hepatitis B virus (HBV) infection.
Study Type
OBSERVATIONAL
Enrollment
600
HBV infection history or HBV carriers
First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
changes of alanine transaminase (ALT, U/L)
The peak increases of ALT from baseline to follow-up
Time frame: one month, three months, six months
number of participants with alanine transaminase (ALT) increasing over 3 folds of upper limit normally (ULN)
Time frame: one month, three months, six months
number of participants with alanine transaminase (ALT) increasing over the ULN
Time frame: one month, three months, six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.